A CFTR mutation (D1152H) in a family with mild lung disease and normal sweat chlorides [1]

Clinical Genetics

Volumn 68, Issue 1, 2005, Pages 88-90

  Highsmith Jr , W E ^b   Friedman, K J ^b   Burch, L H ^b   Spock, A ^b   Silverman, L M ^b   Boucher, R C ^b   Knowles, Michael R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE ION;

ADULT; AGED; BRONCHIECTASIS; CASE REPORT; CLINICAL FEATURE; CYSTIC FIBROSIS; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; LETTER; LUNG DISEASE; MALE; MALE INFERTILITY; NOSE POLYP; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SIBLING; SINUSITIS; SWEAT GLAND; VAS DEFERENS;

AGED; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FAMILY; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MUTATION; REFERENCE VALUES; SWEAT;

PSEUDOMONAS AERUGINOSA;

EID: 20944444227     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2005.00459.x     Document Type: Letter

References (18)

1. Welsh MJ, Ramsey BW, Accurso FJ, Cutting GR. Cystic fibrosis. In: The Metabolic and Molecular Bases of Inherited Disease, 8th edn (Scriver CR, Beaudet AL, Sly WS, Valle D, eds). New York: McGraw-Hill, 2001: 5121-5188.
2. Dean M, Santis G. Heterogeneity in the severity of cystic fibrosis and the role CFTR gene mutations. Hum Genet 1994: 93: 364-368.
3. Highsmith WE Jr. Carrier studies in cystic fibrosis. Clin Chem 1993: 39: 706-707.
4. Sato K, Sato F. Defective beta adrenergic response of cystic fibrosis sweat glands in vivo and in vitro. J Clin Invest 1984: 73: 1763-1771.
5. Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 1995: 6: 447-457.
6. Knowles MR, Robinson JM. Noone P et al. Nasal epithelial bioelectric properties of CF patients with mutations in CFTR associated with pancreatic insufficiency and sufficiency. Pediatr Pulmonol Suppl 1993: 9: 233.
7. Sheppard DN, Rich DP, Ostedgaard LS, Gregory RJ, Smith AE, Welsh MJ. Mutations in CFTR associated with mild disease form CI-channels with altered pore properties. Nature 1993: 362: 160-164.
8. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993: 173: 1251-1254.
9. Vankeerberghen A, Wei L. Teng H et al. Characterization of mutations located in exon 18 of the CFTR gene. FEBS Lett 1998: 437: 1-4.
10. 1992 Cystic Fibrosis Gene Analysis Consortium Newsletter 49 (Internet communication).
11. Friedman KJ, Highsmith WE Jr, Zhou Z et al. D1152H: a common CFTR mutation associated with highly variable disease expression. Pediatr Pulmonol Suppl 1999: 19: 207.
12. Chillon M, Casals T, Mercier B et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995: 332: 1475-1480.
13. Oates RD, Amos JA. The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. J Androl 1994: 15: 1-8.
14. Rave-Harel N, Madgar I, Goshen R et al. CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens. Am J Hum Genet 1995: 56: 1359-1366.
15. Colin AA, Sawyer SM, Mickle JE, Oates RD, Milunsky A, Amos JA. Pulmonary function and clinical observations in men with congenital bilateral absence of the vas deferens. Chest 1996: 110: 440-445.
16. Dork T, Dwomiczak B, Aulehla-Scholz C et al. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet 1997: 100: 365-377.
17. Claustres M, Guittard C, Des Georges M et al. Distinct spectrum of CFTR mutation genotypes in 3591 patients with cystic fibrosis and in 741 patients with congenital absence of the vas deferens in France. Am J Hum Genet 1998: 63 (Suppl.): A356.
18. Quinton PM, Bijman J. Higher bioelectric potentials due to decreased chloride absorption in the sweat glands of patients with cystic fibrosis. N Engl J Med 1983: 308: 1185-1189.